Impaired recycling of surfactant-like liposomes in type II pneumocytes from injured lungs

Thorax

Volumn 58, Issue 2, 2003, Pages 127-134

  Muller B ^a   Garn, H ^a   Hochscheid, R ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPALMITOYLPHOSPHATIDYLCHOLINE; LIPOSOME; LUNG SURFACTANT; NITROGEN DIOXIDE; PHOSPHATIDYLCHOLINE; SURFACTANT PROTEIN A; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; INTERNALIZATION; LIPOGENESIS; LUNG ALVEOLUS CELL TYPE 2; LUNG INJURY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

ANIMALS; CHROMATOGRAPHY, THIN LAYER; LIPOSOMES; LUNG DISEASES; MALE; NITROGEN DIOXIDE; PULMONARY SURFACTANTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0037317496     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.58.2.127     Document Type: Article

References (33)

1. Wright JR, Clements JA. Metabolism and turnover of lung surfactant. Am J Respir Dis 1987;136:426-44.
2. Wright JR. Clearance and recycling of pulmonary surfactant. Am J Physiol 1990;259:L1-12.
3. Hallman M, Epstein BL, Gluck L. Analysis of labeling and clearance of lung surfactant phospholids in the rabbit. J Clin Invest 1981;68:742-51.
4. Geiger K, Gallagher ML, Hedley-Whyte J. Cellular distribution and clearance of aerosolized dipalmitoyl lecithin. J Appl Physiol 1975;39:759-66.
5. Chander A, Claypool WD, Strauss JF, et al. Uptake of liposomal phosphatidylcholine by rat granular pneumocytes in primary culture. Am J Physiol 1983;245:C397-404.
6. Avery MA, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 1959;97:517-23.
7. Hallman M, Spragg R, Harrell JH, et al. Evidence of lung surfactant abnormalities in respiratory failure. J Clin Invest 1976;70:673-83.
8. Müller B, Seifart C, Barth PJ. Effect of air pollutants on the pulmonary surfactant system. Eur J Clin Invest 1998;28:762-77.
9. Fujiwara T, Maeda H, Chida S, et al. Artificial suffactant therapy in hyaline-membrane disease. Lancet 1980;1:55-9.
10. Holm BA, Matalon S, Finkelstein JN, Notter RH. Type II pneumocyte changes during hyperoxic lung injury and recovery. J Appl Physiol 1988;65:2672-8.
11. Müller B, von Wichert P. Effect of nitrogen dioxide inhalation on surfactant phosphatidylcholine synthesis in rat alveolar type II cells. Biochim Biophys Acta 1993;1170:38-43.
12. Wright ES, Mavis RD. Changes in pulmonary biosynthetic enzymes after nitrogen dioxide exposure. Toxicol Appl Pharmacol 1981;58:262-8.
13. Müller B, Barth P, von Wichert P. Structural and functional impairment of surfactant protein A after exposure to nitrogen dioxide in rats. Am J Physiol 1992;263:L177-84.
14. Dobbs LG, Gonzalez R, Williams MC. An improved method for isolating type II cells in high yield and purity. Am Rev Respir Dis 1986;134:141-5.
15. Wissel H, Looman AC, Fritzsche I, et al. SP-A-binding protein BP55 is involved in surfactant endocytosis by type II pneumocytes. Am J Physiol 1996;271:L432-40.
16. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-7.
17. Wissel H, Zastrow S, Richter E, et al. Internalized SP-A and lipid are differently resecreted by type II pneumocytes. Am J Physiol 2000;278:L580-90.
18. Hawgood S, Benson BJ, Hamilton RL. Effects of a surfactant-associated protein and calcium ions on the structure and suface activity of lung surfactant lipids. Biochemistry 1985;24:184-90.
19. Bradford MA. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein dye-binding. Anal Biochem 1976;72:248-54.
20. Bartlett GF. Phosphorus assay in column chromatography. J Biol Chem 1959;234:466-8.
21. Fanestil DD, Barrows CH. Aging in the rotifer. J Gerontol 1965;20:462-9.
22. 2 application mode on phosphatidylcholine metabolism. Am J Respir Cell Mol Biol 1998;18:712-20.
23. Bils RF, Christie BR. The experimental pathology of oxidant and air pollutant inhalation. Int Rev Exp Pathol 1980;21:195-293.
24. Griese M, Beck J, Feuerhake F. Surfactant lipid uptake and metabolism by neonetal and adult type II pneumocytes. Am J Physiol 1999;277:L901-9.
25. Wright JR, Wager RE, Hawgood S, et al. Surfactant apoprotein Mr=26,000-36,000 enhances uptake of liposomes by type II cells. J Biol Chem 1987;262:2888-94.
26. Korfhagen TR, Bruno MD, Ross GF, et al. Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci USA 1996;93:9594-9.
27. Ikegami M, Korfhagen TR, Bruno MD, et al. Surfactant metabolism in surfactant protein A-deficient mice. Am J Physiol 1997;272:L479-85.
28. Tsuzuki A, Kuroki Y, Akino T. Pulmonary surfactant protein A-mediated uptake of phosphatidylcholine by alveolar type II cells. Am J Physiol 1993;265:L193-9.
29. Gilfillan AM, Chu AJ, Rooney SA. Stimulation of phosphatidylcholine synthesis by exogenous phosphatidylglycerol in primary cultures of type II pneumocytes. Biochim Biophys Acta 1984;794:269-73.
30. Robertson B, Halliday HL. Principles of surfactant replacement. Biochim Biophys Acta 1998;1408:346-61.
31. Robertson B, Surfactant inactivation and surfactant therapy in acute respiratory distress syndrome (ARDS). Monaldi Arch Chest Dis 1998;53:64-9.
32. Luchetti M, Casiraghi G, Valsecchi R, et al. Porcine-derived surfactant treatment of severe bronchiolitis. Acta Anaesthesiol Scand 1998;42:805-10.
33. Anzueto A, Jubran A, Ohar JA, et al. Effects of aerosolized surfactant in patients with stable chronic bronchitis. JAMA 1997;278:1426-31.